View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Dr. Terrault discusses results from key viral hepatitis studies reported at the American Association for the Study of Liver Diseases (AASLD) 2020 annual conference, The Liver Meeting Digital Experience, including new findings on HBV treatment and management, hepatocellular carcinoma risk, and emerging approaches to HCV care in underserved populations.
Presenter:
Norah Terrault, MD, MPH
Professor of Medicine
Chief of Gastrointestinal and Liver Diseases
University of Southern California
Los Angeles, California
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
Download this PDF guide outlining key information on HCC risk assessment, screening, and surveillance in the setting of Hepatitis B infection
Robert S. Brown, Jr., MD, MPH
Released: February 22, 2021
Expert CCO commentary on how to incorporate noninvasive methods to assess fibrosis into management of patients with HBV infection
Paul Y. Kwo, MD
Released: February 18, 2021
Watch this brief presentation by Dr. Paul Kwo on interpreting serology, HBV DNA, and fibrosis assessments to determine HBV treatment candidacy.
Paul Y. Kwo, MD
Physicians:
maximum of 0.25 AMA PRA Category 1 Credits™
Registered Nurses:
0.25 Nursing contact hours
Pharmacists:
0.25 contact hours (0.025 CEUs)
Released: February 16, 2021
Expired:
February 15, 2022
Download free expert-authored slides reviewing AASLD guidance on HBV management pretreatment evaluation to determine treatment candidacy
Paul Y. Kwo, MD
Released: February 16, 2021
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.